|Articles|July 1, 2001
- Applied Clinical Trials-07-01-2001
ACT 101 Human Safety in Clinical Research
Pharmaceutical companies must pay close attention to the safety of human subjects at every stage of drug development, as explained in this QA view of the policies and regulations that make the system work.
Advertisement
Articles in this issue
about 25 years ago
Letters to the Editorabout 25 years ago
Conference Reportsabout 25 years ago
Affairs of Stateabout 25 years ago
Pen-Based Computingabout 25 years ago
Some Do--Some Watch Over Those Who Doabout 25 years ago
Communication Skills for Monitors—A Vital Training OpportunityAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
2
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
3
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
4
ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial
5